中华外科杂志
中華外科雜誌
중화외과잡지
CHINESE JOURNAL OF SURGERY
2013年
6期
533-537
,共5页
张晔%李辉%胡滨%侯生才%李彤%苗劲柏%王洋%游宾%傅毅立
張曄%李輝%鬍濱%侯生纔%李彤%苗勁柏%王洋%遊賓%傅毅立
장엽%리휘%호빈%후생재%리동%묘경백%왕양%유빈%부의립
肺切除术%引流术%胸腔积液
肺切除術%引流術%胸腔積液
폐절제술%인류술%흉강적액
Pneumonectomy%Drainage%Pleural effusion
目的 探讨肺叶切除术后早期拔除胸腔引流管的指征以及其安全性.方法 将2012年3至9月70例肺叶切除术患者随机分为两组,其中41例于胸腔引流量≤300 ml/24 h时拔除引流管(早期组),29例于胸腔引流量≤100 ml/24 h时拔除引流管(常规组).记录两组术后24、48 h胸腔引流液的量和性状,检测术后24 h及拔管即刻的胸腔积液常规、生化指标;记录术后胸腔引流管留置时间及术后住院时间,评估术后及早期拔管后胸腔并发症的发生率、再次置管率及胸腔穿刺率.结果 两组患者一般资料、术后24 h胸腔积液常规和生化指标水平差异无统计学意义.全部70例患者术后24、48 h胸腔引流量中位数为300 ml(200~ 400 ml,第一、三四分位数,下同)、250 ml(200 ~300 ml)(Z=-2.059,P=0.039).早期组术后24、48 h平均胸腔引流量为(296±153) ml、(285±103) ml,与常规组(332±149) ml、(252±109) ml差异无统计学意义(P>0.05).早期组术后住院时间中位数为5.0 d(4.5~6.0d),短于常规组的6.0 d(6.0~8.0 d)(Z=-3.882,P=0.000).早期组拔管时间中位数为术后44 h(44 ~68 h),短于常规组的67 h(65 ~90 h)(Z=-2.914,P=0.004).两组术后及拔管后并发症发生率、胸腔积液复发率、再次置管率及胸腔穿刺率差异无统计学意义(P>0.05).结论 将术后拔除胸腔引流管的指征设定为引流量≤300 ml/24 h是可行并且安全有效的,有利于患者术后的快速康复.
目的 探討肺葉切除術後早期拔除胸腔引流管的指徵以及其安全性.方法 將2012年3至9月70例肺葉切除術患者隨機分為兩組,其中41例于胸腔引流量≤300 ml/24 h時拔除引流管(早期組),29例于胸腔引流量≤100 ml/24 h時拔除引流管(常規組).記錄兩組術後24、48 h胸腔引流液的量和性狀,檢測術後24 h及拔管即刻的胸腔積液常規、生化指標;記錄術後胸腔引流管留置時間及術後住院時間,評估術後及早期拔管後胸腔併髮癥的髮生率、再次置管率及胸腔穿刺率.結果 兩組患者一般資料、術後24 h胸腔積液常規和生化指標水平差異無統計學意義.全部70例患者術後24、48 h胸腔引流量中位數為300 ml(200~ 400 ml,第一、三四分位數,下同)、250 ml(200 ~300 ml)(Z=-2.059,P=0.039).早期組術後24、48 h平均胸腔引流量為(296±153) ml、(285±103) ml,與常規組(332±149) ml、(252±109) ml差異無統計學意義(P>0.05).早期組術後住院時間中位數為5.0 d(4.5~6.0d),短于常規組的6.0 d(6.0~8.0 d)(Z=-3.882,P=0.000).早期組拔管時間中位數為術後44 h(44 ~68 h),短于常規組的67 h(65 ~90 h)(Z=-2.914,P=0.004).兩組術後及拔管後併髮癥髮生率、胸腔積液複髮率、再次置管率及胸腔穿刺率差異無統計學意義(P>0.05).結論 將術後拔除胸腔引流管的指徵設定為引流量≤300 ml/24 h是可行併且安全有效的,有利于患者術後的快速康複.
목적 탐토폐협절제술후조기발제흉강인류관적지정이급기안전성.방법 장2012년3지9월70례폐협절제술환자수궤분위량조,기중41례우흉강인류량≤300 ml/24 h시발제인류관(조기조),29례우흉강인류량≤100 ml/24 h시발제인류관(상규조).기록량조술후24、48 h흉강인류액적량화성상,검측술후24 h급발관즉각적흉강적액상규、생화지표;기록술후흉강인류관류치시간급술후주원시간,평고술후급조기발관후흉강병발증적발생솔、재차치관솔급흉강천자솔.결과 량조환자일반자료、술후24 h흉강적액상규화생화지표수평차이무통계학의의.전부70례환자술후24、48 h흉강인류량중위수위300 ml(200~ 400 ml,제일、삼사분위수,하동)、250 ml(200 ~300 ml)(Z=-2.059,P=0.039).조기조술후24、48 h평균흉강인류량위(296±153) ml、(285±103) ml,여상규조(332±149) ml、(252±109) ml차이무통계학의의(P>0.05).조기조술후주원시간중위수위5.0 d(4.5~6.0d),단우상규조적6.0 d(6.0~8.0 d)(Z=-3.882,P=0.000).조기조발관시간중위수위술후44 h(44 ~68 h),단우상규조적67 h(65 ~90 h)(Z=-2.914,P=0.004).량조술후급발관후병발증발생솔、흉강적액복발솔、재차치관솔급흉강천자솔차이무통계학의의(P>0.05).결론 장술후발제흉강인류관적지정설정위인류량≤300 ml/24 h시가행병차안전유효적,유리우환자술후적쾌속강복.
Objective To evaluate the feasibility and safety of early chest tube removal after lobectomies for lung diseases.Methods A prospective randomized control study was performed with data collected from lobectomies between March 2012 and September 2012.Eligible patients (n =70) were randomized into two groups; early removal group (removal of chest tube when drainage less than 300 ml/24 h,n =41) and traditional management group (removal of chest tube when drainage less than 100 ml/24 h,n=29).Criteria for early removal were established and met before chest tube removal.The volume and character of drainage,time of extracting drainage tube and postoperative hospital stay were measured.All patients received standard care during hospital admission and a follow-up visit was performed after 7 days of discharge from hospital.Results There were no differences between two groups with respect to age,sex,comorbidities,or pathologic evaluation of resection specimens.The median volume of drainage within 24 h after surgery was 300 ml and within 48 h was 250 ml,there was significantly different between two groups (Z =-2.059,P =0.039).Patients undergoing early removal management had a shorter Chest tube duration (44 hours vs.67 hours,Z =-2.914,P =0.004) and a shorter postoperative hospital stay (5.0 days vs.6.0 days,Z =-3.882,P =0.000).Analysis of data showed no statistically significant differences between the rate of pleural effusions developed,thoracentesis and complications,one week after discharge from hospital.Conclusions Compared to the traditional management group (drainage ≤100 ml/24 h),early removal of chest tube after lobectomy (drainage ≤300 ml/24 h) is feasible and safe.It could result in a shorter hospital stay,and most importantly,reduces morbidity without the added risk of complications.